阿米卡星/羧苄西林与庆大霉素/羧苄西林对白细胞减少患者的疗效和毒性比较：一项随机前瞻性试验 - Suppr

Suppr

超能文献

Comparative efficacy and toxicity of amikacin/carbenicillin versus gentamicin/carbenicillin in leukopenic patients: a randomized prospective trail.

作者信息

Lau W K, Young L S, Black R E, Winston D J, Linne S R, Weinstein R J, Hewitt W L

出版信息

Am J Med. 1977 Jun;62(6):959-66. doi: 10.1016/0002-9343(77)90669-6.

DOI:10.1016/0002-9343(77)90669-6

PMID:586099

Abstract

摘要

相似文献

Comparative efficacy and toxicity of amikacin/carbenicillin versus gentamicin/carbenicillin in leukopenic patients: a randomized prospective trail.阿米卡星/羧苄西林与庆大霉素/羧苄西林对白细胞减少患者的疗效和毒性比较：一项随机前瞻性试验

Am J Med. 1977 Jun;62(6):959-66. doi: 10.1016/0002-9343(77)90669-6.

A randomized comparative trial of three aminoglycosides--comparison of continuous infusions of gentamicin, amikacin and sisomicin combined with carbenicillin in the treatment of infections in neutropenic patients with malignancies.三种氨基糖苷类药物的随机对照试验——庆大霉素、阿米卡星和西索米星持续输注联合羧苄西林治疗恶性肿瘤中性粒细胞减少患者感染的比较

Medicine (Baltimore). 1979 Mar;58(2):159-70. doi: 10.1097/00005792-197903000-00004.

Controlled comparison of amikacin and gentamicin.阿米卡星与庆大霉素的对照比较。

N Engl J Med. 1977 Feb 17;296(7):349-53. doi: 10.1056/NEJM197702172960701.

Prospective comparative study of efficacy and toxicity of netilmicin and amikacin.奈替米星与阿米卡星疗效及毒性的前瞻性对照研究

Antimicrob Agents Chemother. 1980 Feb;17(2):217-25. doi: 10.1128/AAC.17.2.217.

A prospective, randomized study of amikacin and gentamicin in serious infections with focus on efficacy, toxicity and duration of serum levels above the MIC.一项关于阿米卡星和庆大霉素用于严重感染的前瞻性随机研究，重点关注疗效、毒性以及血清浓度高于最低抑菌浓度的持续时间。

J Antimicrob Chemother. 1983 Oct;12(4):393-402. doi: 10.1093/jac/12.4.393.

Amikacin therapy of gram-negative bacteremia.阿米卡星治疗革兰氏阴性菌血症。

Am J Med. 1977 Jun;62(6):936-9. doi: 10.1016/0002-9343(77)90664-7.

Comparative effectiveness of combinations of amikacin with penicillin G and amikacin with carbenicillin in gram-negative septicemia: double-blind clinical trial.阿米卡星联合青霉素G与阿米卡星联合羧苄西林治疗革兰阴性菌败血症的疗效比较：双盲临床试验

J Infect Dis. 1976 Nov;134 SUPPL:S433-40. doi: 10.1093/infdis/135.supplement_2.s433.

[A case of E. coli septicemia successfully treated with amikacin (author's transl)].1例用丁胺卡那霉素成功治疗的大肠杆菌败血症（作者译）

Jpn J Antibiot. 1975 Oct;28(5):655-6.

Treatment and prevention of bacterial infections during cytostatic chemotherapy.细胞毒性化疗期间细菌感染的治疗与预防

Acta Clin Belg. 1981;36(3):162-6. doi: 10.1080/22953337.1981.11718802.

Aminoglycoside-related nephrotoxicity in the premature newborn.

Clin Pharmacol Ther. 1984 Mar;35(3):394-401. doi: 10.1038/clpt.1984.49.

引用本文的文献

The pharmaco -, population and evolutionary dynamics of multi-drug therapy: experiments with S. aureus and E. coli and computer simulations.多药治疗的药物动力学、人群动力学和进化动力学：金黄色葡萄球菌和大肠杆菌的实验和计算机模拟。

PLoS Pathog. 2013;9(4):e1003300. doi: 10.1371/journal.ppat.1003300. Epub 2013 Apr 4.

Economic impact of aminoglycoside toxicity and its prevention through therapeutic drug monitoring.氨基糖苷类药物毒性的经济影响及其通过治疗药物监测进行的预防。

Pharmacoeconomics. 1998 Oct;14(4):385-94. doi: 10.2165/00019053-199814040-00005.

Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test.三种不同体外检测协同作用方法的比较：时间杀菌法、棋盘法和E试验。

Antimicrob Agents Chemother. 1996 Aug;40(8):1914-8. doi: 10.1128/AAC.40.8.1914.

Double beta-lactam regimen compared to an aminoglycoside/beta-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.对于发热性粒细胞减少的癌症患者，将双β-内酰胺方案与氨基糖苷类/β-内酰胺方案作为经验性抗生素治疗进行比较。

Support Care Cancer. 1993 Jul;1(4):186-94. doi: 10.1007/BF00366445.

Empiric antibiotic therapy for granulocytopenic patients.粒细胞减少症患者的经验性抗生素治疗。

Bull N Y Acad Med. 1982 Nov;58(8):750-6.

Management of the febrile neutropenic patient.发热性中性粒细胞减少症患者的管理。

Can Med Assoc J. 1983 Apr 15;128(8):915-7.

Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens.新型β-内酰胺类抗菌剂与阿米卡星对铜绿假单胞菌和粘质沙雷氏菌的体外协同活性比较

Antimicrob Agents Chemother. 1981 Aug;20(2):239-43. doi: 10.1128/AAC.20.2.239.

Methodological variation in antibiotic synergy tests against enterococci.针对肠球菌的抗生素协同试验中的方法学差异。

J Clin Microbiol. 1981 Jan;13(1):73-5. doi: 10.1128/jcm.13.1.73-75.1981.

Synergism at clinically attainable concentrations of aminoglycoside and beta-lactam antibiotics.氨基糖苷类抗生素与β-内酰胺类抗生素在临床可达到浓度下的协同作用。

Antimicrob Agents Chemother. 1984 Oct;26(4):535-8. doi: 10.1128/AAC.26.4.535.

In vitro susceptibility of 104 clinical isolates of Haemophilus influenzae to moxalactam (LY127935), ampicillin, chloramphenicol, and ticarcillin.104株流感嗜血杆菌临床分离株对羟羧氧酰胺菌素（LY127935）、氨苄西林、氯霉素和替卡西林的体外敏感性

Antimicrob Agents Chemother. 1980 Mar;17(3):470-3. doi: 10.1128/AAC.17.3.470.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验